These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 484570)

  • 1. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
    Juhl RP
    Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
    Easom JM; Caraccio TR; Lovejoy FH
    Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.
    Curtis RA; Barone J; Giacona N
    Arch Intern Med; 1984 Jan; 144(1):48-52. PubMed ID: 6140906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased bioavailability of digoxin due to antacids and kaolin-pectin.
    Brown DD; Juhl RP
    N Engl J Med; 1976 Nov; 295(19):1034-7. PubMed ID: 972657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by ice cream of the antidotal efficacy of activated charcoal.
    Levy G; Soda DM; Lampman TA
    Am J Hosp Pharm; 1975 Mar; 32(3):289-91. PubMed ID: 1136978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of kaolin--pectin suspension on digoxin bioavailability.
    Albert KS; Ayres JW; DiSanto AR; Weidler DJ; Sakmar E; Hallmark MR; Stoll RG; DeSante KA; Wagner JG
    J Pharm Sci; 1978 Nov; 67(11):1582-6. PubMed ID: 712596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic evaluation of a drug interaction between kaolin--pectin and clindamycin.
    Albert KS; DeSante KA; Welch RD; DiSanto AR
    J Pharm Sci; 1978 Nov; 67(11):1579-82. PubMed ID: 712595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a charcoal-sorbitol mixture as an antidote for oral aspirin overdose.
    Mayersohn M; Perrier D; Picchioni AL
    Clin Toxicol; 1977 Dec; 11(5):561-7. PubMed ID: 608318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.
    Neuvonen PJ; Elfving SM; Elonen E
    Eur J Clin Pharmacol; 1978 May; 13(3):213-8. PubMed ID: 668776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible adsorption (desorption) of aspirin from activated charcoal.
    Filippone GA; Fish SS; Lacouture PG; Scavone JM; Lovejoy FH
    Arch Intern Med; 1987 Aug; 147(8):1390-2. PubMed ID: 3632148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-volume whole bowel irrigation and salicylate absorption: a comparison with ipecac-charcoal.
    Olsen KM; Ma FH; Ackerman BH; Stull RE
    Pharmacotherapy; 1993; 13(3):229-32. PubMed ID: 8100628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pectin and kaolin on bioavailability of co-trimoxazole suspension.
    Gupta KC; Desai NK; Satoskar RS; Gupta C; Goswami SN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):320-1. PubMed ID: 3497885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of activated charcoal on rifampicin absorption in man.
    Orisakwe OE; Dioka CE; Okpogba AN; Orish CN; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):51-4. PubMed ID: 9239805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of a kaolin-pectin combination on the intestinal absorption of sodium and water when using hydration solutions].
    Vega-Franco L; Velasco-Sánchez F; Covarrubias M
    Bol Med Hosp Infant Mex; 1988 Sep; 45(9):583-7. PubMed ID: 3190850
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man.
    Scholtz EC; Jaffe JM; Colaizzi JL
    Am J Hosp Pharm; 1978 Nov; 35(11):1355-9. PubMed ID: 707504
    [No Abstract]   [Full Text] [Related]  

  • 17. Activated charcoal-carboxymethylcellulose gel formulation as an antidotal agent for orally ingested aspirin.
    Mathur LK; Jaffe JM; Colaizzi JL; Moriarty RW
    Am J Hosp Pharm; 1976 Jul; 33(7):717-9. PubMed ID: 941924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose evaluation of a new enteric-coated aspirin preparation.
    Paull P; Day R; Graham G; Champion D
    Med J Aust; 1976 Apr; 1(17):617-9. PubMed ID: 933973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of activated charcoal on aspirin absorption in man. Part I.
    Levy G; Tsuchiya T
    Clin Pharmacol Ther; 1972; 13(3):317-22. PubMed ID: 5026372
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental study of the treatment of salicylate poisoning by activated charcoal].
    Collombel C; Perrot L
    Eur J Toxicol; 1970; 3(6):352-4. PubMed ID: 5520489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.